Evaluation on efficacy of long period antidepressant drug therapy in COPD-associated depression

Depression Paroxetine
DOI: 10.3760/cma.j.issn.1007-1245.2012.14.017 Publication Date: 2012-07-15
ABSTRACT
[Objective]To evaluate the efficacy of antidepressant drug therapy in COPD-associated depression.[Methods]Outpatients were evaluated with moderate to severe,stable COPD completed Hospital Anxiety and Depression (HAD).Those psychiatrist interviewed high score s [HADS scale(anxiety or depression score) > 10]were brought into study.Depressed anxious patients took a selective serotonin reuptake inhibitor,paroxetine 20 mg daily.All paroxetine for 16 weeks.After 2,8,12 weeks,the HADS was repeated.[Results]Among 41outpatients who entered study,29 study.Anxiety (only anxiety 10) indicated 9 patienta 5,anxiety (HADS anxiety+depression all 15.12 weeks' treatment produced significant improvement either depression(P< 0.05).However,there no differences scales at 12 weeks weeks(P> 0.05).[Conclusion]We conclude that least can produce depression.Longer period could not acquire better curative effect. Key words: Chronic obstructive pulmonary disease; Anxiety; Depression; Drug
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....